Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke
Clinical trial NCT03815292 · COMPLETED
Trial details
- NCT number
- NCT03815292
- Sponsor
- Materia Medica Holding
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-19
- Primary completion
- 2020-01-27
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.